Ultra Drugs Formulations Private Limited - Company Profile

It is a pharma private limited company based in Baddi, Himachal Pradesh, India, established in 2020.
2020 Baddi, Himachal Pradesh, India Active
Last Updated:
Access Report
About Ultra Drugs Formulations Private Limited

Ultra Drugs Formulations Private Limited, a active private limited company, was established on 04 February 2020 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100HP2020PTC007802. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

Employing 74 professional, Its leadership includes Sandeep Kumar Arora (Director), Minna Jakhar (Director), Sangram Singh (Nominee Director). It holds ₹15.96 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Khatta/Khatauni No. 38/39 Khasra No. 338/278 & 279 Village Manakpur, Baddi, Himachal Pradesh, 173205.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100HP2020PTC007802

  • Registration Number

    007802

  • Incorporation Date

    04 February 2020

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 6 Year, 26 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 15.96 Cr
  • Revenue Growth **** %
  • Net Worth -36.30%
  • Total Assets **** 221.24%
Company report

Ultra Drugs Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ultra Drugs Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ultra Drugs Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Kumar Arora Director 04 Feb 2020 Current
Minna Jakhar Director 04 Feb 2020 Current
Sangram Singh Nominee Director 04 Feb 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ultra Drugs Formulations.

Ultra Drugs Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.3%.

Ultra Drugs Formulations revenue growth over time
Ultra Drugs Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 221.24%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 -36.30%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ultra Drugs Formulations?

In 2023, Ultra Drugs Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹159,600,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 10.60 Cr
  • Hdfc Bank Limited : 5.36 Cr
Latest Charge Details
Date Lender Amount Status
26 Jun 2025 Others ₹10.60 Cr Open
16 Feb 2022 Hdfc Bank Limited ₹5.36 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Ultra Drugs Formulations?

Ultra Drugs Formulations has a workforce of 74 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ultra Drugs Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Drugs Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ultra Drugs Formulations
Recent Activity within the Organization
  • Charges

    The activity A charge with Others of Rs. 10.60 Cr registered on 26 Jun 2025 with Charge ID 101115964 was modified on 06 Nov 2025. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 5.36 Cr registered on 16 Feb 2022 with Charge ID 100551319 was modified on 06 Nov 2025. was documented.

  • Annual General Meeting

    Ultra Drugs Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 10.60 Cr with Charge ID 101115964 was registered on 26 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    Ultra Drugs Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 5.36 Cr with Charge ID 100551319 was registered on 16 Feb 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ultra Drugs Formulations Private Limited?

The CIN of Ultra Drugs Formulations Private Limited is U85100HP2020PTC007802.

Where is Ultra Drugs Formulations Private Limited headquartered?

Ultra Drugs Formulations Private Limited is headquartered at Khatta/Khatauni No. 38/39 Khasra No. 338/278 & 279 Village Manakpur, Baddi, Himachal Pradesh, 173205.

When was Ultra Drugs Formulations Private Limited incorporated?

Ultra Drugs Formulations Private Limited was incorporated on 04 February 2020.

Who are the current directors of Ultra Drugs Formulations Private Limited?

The current directors of Ultra Drugs Formulations Private Limited are

What is the primary industry of Ultra Drugs Formulations Private Limited?

The primary industry of Ultra Drugs Formulations Private Limited is Manufacturing.

Is Ultra Drugs Formulations Private Limited a listed company?

Ultra Drugs Formulations Private Limited is unlisted.

What is the capital structure of Ultra Drugs Formulations Private Limited?

The authorized capital of Ultra Drugs Formulations Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available